Recall Overview
According to a report from the U.S. Food and Drug Administration (FDA), pharmaceutical company Strides Pharma Inc. initiated a voluntary nationwide recall on March 2, 2026. The recall involves approximately 89,592 bottles of Children's Ibuprofen Oral Suspension (USP, 100 mg/5 mL) following complaints about the presence of a "gel-like mass and black particles" in the product.
Recall Details and Risk Classification
The recalled product is in 4 fl. oz. (approximately 118 mL) bottles, manufactured by Taro Pharmaceuticals and distributed to retailers nationwide. The FDA classified this recall as a Class II recall on March 16. This signifies that exposure to the product may cause temporary or medically reversible adverse health consequences.
Affected Product Information
Please check your children's ibuprofen medication immediately for the following details:
- Product Name: Children's Ibuprofen Oral Suspension, USP, 100 mg per 5 mL
- Size: 4 fl. oz. (approx. 118 mL)
- Expiration Date: January 31, 2027
- Affected Lot Numbers:
- 7261973A
- 7261974A
What Should Consumers Do?
If you have medication from the affected lot numbers, discontinue use immediately. You may return it to the place of purchase for a refund or dispose of it safely according to local guidelines. The exact number of complaints or any reports of injury are not yet clear, but caution is advised.
About Drug Recalls
A drug recall is an action taken to remove products from the market that present a risk of injury, gross deception, or are otherwise defective, in order to protect public health. Parents are encouraged to stay informed about medication safety alerts from official sources.